Back to top
more

HEXO Corp. (HEXO)

(Delayed Data from AMEX)

$7.73 USD

7.73
4,769,165

+0.27 (3.62%)

Updated May 3, 2019 04:00 PM ET

After-Market: $7.72 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

HEXO (HEXO) Reports Q3 Loss, Lags Revenue Estimates

HEXO (HEXO) delivered earnings and revenue surprises of -900% and 15.51%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?

The Cooper Companies (COO) Q2 Earnings and Revenues Surpass Estimates

The Cooper Companies (COO) delivered earnings and revenue surprises of 2.33% and 1.75%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 44.44% and 4.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

HEXO (HEXO) Reports Q2 Loss, Lags Revenue Estimates

HEXO (HEXO) delivered earnings and revenue surprises of 13.64% and 33.97%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 34.09% and 0.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Will HEXO (HEXO) Report Negative Q2 Earnings? What You Should Know

HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

National Vision (EYE) Reports Q4 Loss, Misses Revenue Estimates

National Vision (EYE) delivered earnings and revenue surprises of -33.33% and 0.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Perrigo (PRGO) Tops Q4 Earnings Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of 7.14% and 3.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

HEXO (HEXO) Reports Q1 Loss, Misses Revenue Estimates

HEXO (HEXO) delivered earnings and revenue surprises of -250% and 19.23%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know

HEXO (HEXO) closed at $0.16 in the latest trading session, marking a -0.25% move from the prior day.

Will HEXO (HEXO) Report Negative Q1 Earnings? What You Should Know

HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Acer Therapeutics Inc. (ACER) Reports Q1 Loss, Misses Revenue Estimates

Acer Therapeutics Inc. (ACER) delivered earnings and revenue surprises of -172.22% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Clover Health (CLOV) to Report Q1 Earnings: What's in Store?

Clover Health's (CLOV) first-quarter results are likely to reflect benefits from Clover Assistant management.

Here's Why HEXO (HEXO) Is a Great 'Buy the Bottom' Stock Now

HEXO (HEXO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

PetIQ (PETQ) Reports Q4 Loss, Tops Revenue Estimates

PetIQ (PETQ) delivered earnings and revenue surprises of -200% and 15.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

National Vision (EYE) Tops Q4 Earnings and Revenue Estimates

National Vision (EYE) delivered earnings and revenue surprises of 750% and 4.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Lantheus Holdings (LNTH) Q4 Earnings and Revenues Top Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 47.06% and 14.81%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of -15.38% and 0.99%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Do Options Traders Know Something About HEXO Stock We Don't?

Investors need to pay close attention to HEXO stock based on the movements in the options market lately.

HEXO (HEXO) Reports Q1 Loss, Lags Revenue Estimates

HEXO (HEXO) delivered earnings and revenue surprises of 10% and 12.36%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: HEXO (HEXO) Q1 Earnings Expected to Decline

HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Implied Volatility Surging for HEXO Corp (HEXO) Stock Options

Investors need to pay close attention to HEXO Corp (HEXO) stock based on the movements in the options market lately.

Sanghamitra Saha headshot

5 Top Inverse/Leveraged ETFs of Last Week

Big three U.S. indexes including the S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 made last week a winning one for investors.

HEXO (HEXO) Reports Q4 Loss, Tops Revenue Estimates

HEXO (HEXO) delivered earnings and revenue surprises of -66.67% and 20.00%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?